$10.9 Billion is the total value of HHLR ADVISORS, LTD.'s 74 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 36.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ZM | Buy | ZOOM VIDEO COMMUNICATIONS INcl a | $1,738,519,000 | +92.1% | 6,856,980 | +10.7% | 15.89% | +30.3% |
IQ | IQIYI INCsponsored ads | $1,082,848,000 | +30.3% | 46,694,629 | 0.0% | 9.90% | -11.6% | |
BGNE | BEIGENE LTDsponsored adr | $1,030,974,000 | +53.0% | 5,472,259 | 0.0% | 9.42% | +3.8% | |
BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $847,720,000 | +120.2% | 3,930,086 | +98.5% | 7.75% | +49.3% |
PDD | Buy | PINDUODUO INCsponsored ads | $846,714,000 | +169.2% | 9,863,866 | +13.0% | 7.74% | +82.6% |
UBER | UBER TECHNOLOGIES INC | $598,623,000 | +11.3% | 19,260,700 | 0.0% | 5.47% | -24.5% | |
TAL | Buy | TAL EDUCATION GROUPsponsored ads | $540,615,000 | +35.2% | 7,906,041 | +5.3% | 4.94% | -8.3% |
JD | Sell | JD.COM INCspon adr cl a | $470,030,000 | -2.5% | 7,810,402 | -34.4% | 4.30% | -33.9% |
BILI | Sell | BILIBILI INCspons ads rep z | $421,608,000 | +76.2% | 9,102,063 | -10.9% | 3.85% | +19.5% |
CBPO | Buy | CHINA BIOLOGIC PRODS HLDGS I | $302,665,000 | +1.9% | 2,962,076 | +7.7% | 2.77% | -30.9% |
ESGR | ENSTAR GROUP LIMITED | $267,018,000 | -3.9% | 1,747,840 | 0.0% | 2.44% | -34.9% | |
ALGN | Sell | ALIGN TECHNOLOGY INC | $216,908,000 | +16.9% | 790,365 | -25.9% | 1.98% | -20.7% |
APLS | APELLIS PHARMACEUTICALS INC | $164,224,000 | +21.9% | 5,028,289 | 0.0% | 1.50% | -17.3% | |
FGEN | FIBROGEN INC | $160,328,000 | +16.6% | 3,955,787 | 0.0% | 1.47% | -20.9% | |
BBIO | BRIDGEBIO PHARMA INC | $153,645,000 | +12.4% | 4,711,604 | 0.0% | 1.40% | -23.7% | |
TSLA | TESLA INC | $140,783,000 | +106.1% | 130,378 | 0.0% | 1.29% | +39.7% | |
CRM | Buy | SALESFORCE COM INC | $132,910,000 | +67.7% | 709,495 | +28.9% | 1.22% | +13.8% |
ZTO | ZTO EXPRESS CAYMAN INCsponsored ads a | $126,047,000 | +38.6% | 3,433,592 | 0.0% | 1.15% | -6.0% | |
MDLZ | Sell | MONDELEZ INTL INCcl a | $124,305,000 | -2.5% | 2,431,164 | -4.5% | 1.14% | -33.9% |
VIE | Sell | VIELA BIO INC | $121,983,000 | -30.1% | 2,815,868 | -38.7% | 1.12% | -52.6% |
VIPS | Sell | VIPSHOP HOLDINGS LIMITEDsponsored ads a | $109,055,000 | -0.6% | 5,477,392 | -22.3% | 1.00% | -32.6% |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $106,441,000 | +12.8% | 1,364,631 | -15.4% | 0.97% | -23.5% |
ARGX | Buy | ARGENX SEsponsored adr | $105,858,000 | +1507.1% | 470,000 | +840.0% | 0.97% | +987.6% |
GOSS | Buy | GOSSAMER BIO INC | $96,473,000 | +60.8% | 7,420,974 | +25.5% | 0.88% | +9.0% |
BEAM | BEAM THERAPEUTICS INCcl a | $83,059,000 | +55.6% | 2,966,403 | 0.0% | 0.76% | +5.4% | |
MYOK | Sell | MYOKARDIA INC | $66,731,000 | +45.8% | 690,658 | -29.2% | 0.61% | -1.1% |
SE | Sell | SEA LTDsponsored ads | $64,182,000 | +15.9% | 598,489 | -52.1% | 0.59% | -21.3% |
TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $62,475,000 | – | 1,100,495 | +100.0% | 0.57% | – |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $62,269,000 | +112.2% | 2,443,833 | +28.9% | 0.57% | +43.7% |
GMAB | GENMAB A/Ssponsored ads | $50,835,000 | +59.9% | 1,500,000 | 0.0% | 0.46% | +8.6% | |
OTIS | New | OTIS WORLDWIDE CORP | $34,944,000 | – | 614,556 | +100.0% | 0.32% | – |
ALLO | New | ALLOGENE THERAPEUTICS INC | $34,256,000 | – | 800,000 | +100.0% | 0.31% | – |
LN | Sell | LINE CORPsponsored adr | $33,858,000 | -19.3% | 676,211 | -22.4% | 0.31% | -45.3% |
ZLAB | Sell | ZAI LAB LTDadr | $32,852,000 | +15.6% | 400,000 | -27.6% | 0.30% | -21.7% |
BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $31,328,000 | +16.8% | 3,985,797 | 0.0% | 0.29% | -21.0% | |
LEGN | New | LEGEND BIOTECH CORPsponsored ads | $27,664,000 | – | 650,000 | +100.0% | 0.25% | – |
NVAX | New | NOVAVAX INC | $27,175,000 | – | 326,038 | +100.0% | 0.25% | – |
MLCO | Sell | MELCO RESORT ENTMNT LTDadr | $26,367,000 | -3.3% | 1,698,877 | -22.7% | 0.24% | -34.3% |
AKRO | Buy | AKERO THERAPEUTICS INC | $26,332,000 | +39.4% | 1,056,673 | +18.6% | 0.24% | -5.5% |
IGMS | IGM BIOSCIENCES INC | $25,550,000 | +30.0% | 350,000 | 0.0% | 0.23% | -11.7% | |
AMG | Buy | AFFILIATED MANAGERS GROUP IN | $24,983,000 | +37.8% | 335,073 | +9.3% | 0.23% | -6.6% |
ADCT | New | ADC THERAPEUTICS SA | $23,405,000 | – | 500,000 | +100.0% | 0.21% | – |
FMTX | New | FORMA THERAPEUTICS HLDGS INC | $23,245,000 | – | 500,000 | +100.0% | 0.21% | – |
GTHX | G1 THERAPEUTICS INC | $23,033,000 | +120.1% | 949,431 | 0.0% | 0.21% | +49.6% | |
YY | New | JOYY INC | $21,206,000 | – | 239,476 | +100.0% | 0.19% | – |
ARVN | Sell | ARVINAS INC | $20,963,000 | -39.2% | 625,000 | -26.9% | 0.19% | -58.7% |
MOGU | MOGU INCspon ads | $18,805,000 | +57.2% | 10,446,970 | 0.0% | 0.17% | +6.8% | |
RGNX | REGENXBIO INC | $16,794,000 | +13.7% | 456,000 | 0.0% | 0.15% | -22.6% | |
RCUS | Sell | ARCUS BIOSCIENCES INC | $15,463,000 | +45.2% | 625,000 | -18.5% | 0.14% | -2.1% |
NXTC | Sell | NEXTCURE INC | $13,685,000 | -65.0% | 638,307 | -39.4% | 0.12% | -76.2% |
RNA | New | AVIDITY BIOSCIENCES INC | $12,011,000 | – | 425,000 | +100.0% | 0.11% | – |
GRUB | GRUBHUB INC | $11,908,000 | +72.6% | 169,386 | 0.0% | 0.11% | +17.2% | |
HOOK | HOOKIPA PHARMA INC | $10,961,000 | +40.9% | 943,254 | 0.0% | 0.10% | -4.8% | |
BNR | New | BURNING ROCK BIOTECH LTDsponsored ads | $10,804,000 | – | 400,000 | +100.0% | 0.10% | – |
MRUS | MERUS N V | $9,654,000 | +33.0% | 600,000 | 0.0% | 0.09% | -10.2% | |
EIDX | EIDOS THERAPEUTICS INC | $8,514,000 | -2.7% | 178,600 | 0.0% | 0.08% | -33.9% | |
CALT | New | CALLIDITAS THERAPEUTICS ABsponsered ads | $8,155,000 | – | 350,000 | +100.0% | 0.08% | – |
LPTX | New | LEAP THERAPEUTICS INC | $7,532,000 | – | 3,604,040 | +100.0% | 0.07% | – |
SOHU | SOHU COM LTDsponsored ads | $7,387,000 | +47.8% | 802,034 | 0.0% | 0.07% | +1.5% | |
PASG | PASSAGE BIO INC | $6,849,000 | +73.5% | 250,616 | 0.0% | 0.06% | +18.9% | |
TXG | 10X GENOMICS INC | $6,698,000 | +43.3% | 75,000 | 0.0% | 0.06% | -3.2% | |
CJJD | CHINA JO-JO DRUGSTORES INC | $6,679,000 | -23.8% | 4,840,000 | 0.0% | 0.06% | -48.3% | |
KDP | New | KEURIG DR PEPPER INC | $6,008,000 | – | 211,556 | +100.0% | 0.06% | – |
GDS | New | GDS HLDGS LTDsponsored ads | $5,313,000 | – | 66,700 | +100.0% | 0.05% | – |
TCRR | TCR2 THERAPEUTICS INC | $4,960,000 | +98.5% | 322,903 | 0.0% | 0.04% | +32.4% | |
HTHT | New | HUAZHU GROUP LTDsponsored ads | $4,514,000 | – | 128,786 | +100.0% | 0.04% | – |
UXIN | Sell | UXIN LTDads | $4,285,000 | -61.6% | 2,996,543 | -58.6% | 0.04% | -74.0% |
CBMG | CELLULAR BIOMEDICINE GROUP I | $3,521,000 | -5.4% | 235,214 | 0.0% | 0.03% | -36.0% | |
CVET | COVETRUS INC | $2,775,000 | +119.7% | 155,124 | 0.0% | 0.02% | +47.1% | |
API | New | AGORA INCads | $1,327,000 | – | 30,050 | +100.0% | 0.01% | – |
CIH | CHINA INDEX HLDGS LTDspnsrd ads a | $642,000 | +58.5% | 300,000 | 0.0% | 0.01% | +20.0% | |
NEW | PUXIN LTDads | $651,000 | +20.6% | 126,145 | 0.0% | 0.01% | -14.3% | |
MREO | New | MEREO BIOPHARMA GROUP PLCads | $382,000 | – | 124,970 | +100.0% | 0.00% | – |
SFUN | New | FANG HLDGS LTDadr new | $340,000 | – | 30,000 | +100.0% | 0.00% | – |
SFUN | Exit | FANG HLDGS LTDadr new | $0 | – | -300,000 | -100.0% | -0.01% | – |
NVDA | Exit | NVIDIA CORP | $0 | – | -50,000 | -100.0% | -0.18% | – |
SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -2,898,086 | -100.0% | -0.18% | – |
SNAP | Exit | SNAP INCcl a | $0 | – | -4,465,885 | -100.0% | -0.72% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BEIGENE LTD | 20 | Q3 2023 | 26.0% |
JD.COM INC | 20 | Q3 2023 | 13.1% |
IQIYI INC | 20 | Q3 2023 | 12.3% |
MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
SOHU COM LTD | 20 | Q3 2023 | 0.6% |
PINDUODUO INC | 19 | Q3 2023 | 16.1% |
GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
4 | 2024-02-01 |
13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.